Back to search results

Implementing Contingency Management for Stimulant Use in Addiction Treatment

This study aims to improve how a treatment called Contingency Management (CM) is used in addiction treatment centers. CM is a proven method that uses rewards to help people stop using stimulants, which are a growing concern alongside the opioid epidemic. While CM is effective, it's not widely used in programs that treat opioid use disorder. This study will test a strategy called the Science of Service Laboratory to help counselors learn and use CM more often. The goal is to see how much the use of CM increases among both patients and counselors over 10 months. You may be eligible to participate if you are an Opioid Treatment Program counselor, aged 18 or older, providing ongoing support to patients and have an active caseload. The study is currently unclear on its recruitment status.

Study design
This is an interventional study with a planned enrollment of 76 participants. It is designed to evaluate a multi-level implementation strategy.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcomes are measured at 10 months after implementation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05702021

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

Recruiting
NAAges 18+InterventionalHealth services
Northwestern University
~76 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:Science to Service Laboratory

At a glance

Recruiting sites
4 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in percent of patients receiving contingency management from pre-implementation to post-implementation
Measured over 10 months
+1 more outcome measured

Conditions

Stimulant Use (Diagnosis)

Explore related trials

Opioid Use DisorderStimulant Use

Where it's being run

9 sites across 2 states
Illinois6
Rhode Island3

Study leadership

  • Sara Becker · PRINCIPAL_INVESTIGATOR · Northwestern University

Who to contact

Sara Becker
[email protected]
312-503-1709
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Persons on Medication for Opioid Use Disorder \[Not recruited, via electronic medical records only\]

What this trial measures

  • Change in percent of patients receiving contingency management from pre-implementation to post-implementation10 months

    This is an implementation outcome capturing Reach and is extracted from electronic medical records. This is a patient-level measure of the change in the percent of newly inducted patients with a history of stimulant use who are documented as having received 1 or more contingency management sessions from pre-implementation to post-implementation.

  • Change in percent of counselors delivering contingency management from pre-implementation to post-implementation10 months

    This is an implementation outcome capturing Adoption and is extracted from electronic medical records. This is a provider-level measure of the change in percent of counselors at each program who are documented as having delivered 1 or more contingency management sessions from pre-implementation to post-implementation.